Endonovo Therapeutics Inc (ENDV):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Endonovo Therapeutics Inc (ENDV) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C9442
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:27
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Endonovo Therapeutics Inc (Endonovo Therapeutics) is a commercial stage development company that offers non-invasive medical devices and equipment. The company’s products include Electroceutical Therapy a FDA-Cleared for the palliative treatment of pain and post-surgical edema and CE Marked for the promotion of wound healing and the palliative treatment of pain and post-surgical edema. Its Electroceutical Therapy has CMS National Coverage for the treatment of chronic wounds. Endonovo Therapeutics’ pipeline of clinical-stage Electroceutical Therapies targets cardiovascular diseases and central nervous system disorders such as acute concussions, post-concussion syndrome, ischemic heart disease, traumatic brain injury and multiple sclerosis. The company’s Electroceuticals are electronic devices designed to affect biological systems to alleviate or mitigate symptomatology and pathology. Endonovo Therapeutics is headquartered in Woodland Hills, California, the US.

Endonovo Therapeutics Inc (ENDV) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Endonovo Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Endonovo Therapeutics Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Endonovo Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Endonovo Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Endonovo Therapeutics Inc, Medical Devices Deals, 2012 to YTD 2018 9
Endonovo Therapeutics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Endonovo Therapeutics Inc, Pharmaceuticals & Healthcare, Deal Details 11
Asset Purchase 11
Endonovo Therapeutics Acquires PEMF Assets from Rio Grande Neurosciences for USD4.5 million 11
Venture Financing 12
Endonovo Therapeutics Raises USD0.7 Million in Venture Financing 12
Endonovo Therapeutics Raises USD0.21 Million in Venture Financing 13
Endonovo Therapeutics Raises USD0.1 Million in Financing 14
Endonovo Therapeutics Raises Funds through Financing 15
Equity Offering 16
Endonovo Therapeutics to Raise Funds through Private Placement of Shares 16
Endonovo Therapeutics to Raise USD3 Million in Private Placement of Shares 18
Debt Offering 19
Endonovo Therapeutics Raises USD0.2 Million in Private Placement of 10% Notes Due 2018 19
Endonovo Therapeutics Raises USD0.6 Million in First Tranche of Private Placement of Notes 20
Endonovo Therapeutics Raises USD0.4 Million in First Tranche of Private Placement of 6% Notes 21
Endonovo Therapeutics Inc – Key Competitors 22
Endonovo Therapeutics Inc – Key Employees 23
Endonovo Therapeutics Inc – Locations And Subsidiaries 24
Head Office 24
Recent Developments 25
Strategy And Business Planning 25
Jan 16, 2018: Endonovo Therapeutics Provides Corporate Update and 2018 Outlook 25
Appendix 27
Methodology 27
About GlobalData 27
Contact Us 27
Disclaimer 27

List of Tables
Endonovo Therapeutics Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Endonovo Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Endonovo Therapeutics Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Endonovo Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Endonovo Therapeutics Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Endonovo Therapeutics Inc, Medical Devices Deals, 2012 to YTD 2018 9
Endonovo Therapeutics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Endonovo Therapeutics Acquires PEMF Assets from Rio Grande Neurosciences for USD4.5 million 11
Endonovo Therapeutics Raises USD0.7 Million in Venture Financing 12
Endonovo Therapeutics Raises USD0.21 Million in Venture Financing 13
Endonovo Therapeutics Raises USD0.1 Million in Financing 14
Endonovo Therapeutics Raises Funds through Financing 15
Endonovo Therapeutics to Raise Funds through Private Placement of Shares 16
Endonovo Therapeutics to Raise USD3 Million in Private Placement of Shares 18
Endonovo Therapeutics Raises USD0.2 Million in Private Placement of 10% Notes Due 2018 19
Endonovo Therapeutics Raises USD0.6 Million in First Tranche of Private Placement of Notes 20
Endonovo Therapeutics Raises USD0.4 Million in First Tranche of Private Placement of 6% Notes 21
Endonovo Therapeutics Inc, Key Competitors 22
Endonovo Therapeutics Inc, Key Employees 23

List of Figures
Endonovo Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Endonovo Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Endonovo Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Endonovo Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Endonovo Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Endonovo Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Endonovo Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Endonovo Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Endonovo Therapeutics Inc, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Endonovo Therapeutics Inc (ENDV):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Mahanagar Telephone Nigam Ltd (MTNL):企業の財務・戦略的SWOT分析
    Mahanagar Telephone Nigam Ltd (MTNL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • JHL Biotech Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary JHL Biotech Inc (JHL Biotech) is a biologic medicines provider. The company offers cell line construction, process development, manufacturing, quality and regulatory services. It offers products such as biosimilar rituximab, biosimilar dornase alfa, biosimilar bevacizumab, biosimilar trastuz …
  • Acom Co., Ltd.:企業の戦略・SWOT・財務情報
    Acom Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Acom Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Esperion Therapeutics Inc (ESPR):製薬・医療:M&Aディール及び事業提携情報
    Summary Esperion Therapeutics Inc (Esperion), a subsidiary of Pfizer Inc is a pharmaceutical company that develops and commercializes once-daily, oral and low-density lipoprotein cholesterol lowering therapies. The company develops oral therapies to treat patients with elevated low-density lipoprote …
  • Fidelity Investments Inc:企業のM&A・事業提携・投資動向
    Fidelity Investments Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Fidelity Investments Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisiti …
  • Tokio Marine Holdings, Inc.:戦略・SWOT・企業財務分析
    Tokio Marine Holdings, Inc. - Strategy, SWOT and Corporate Finance Report Summary Tokio Marine Holdings, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Guess, Inc.:企業の戦略・SWOT・財務情報
    Guess, Inc. - Strategy, SWOT and Corporate Finance Report Summary Guess, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • The Gap, Inc.:企業の戦略・SWOT・財務情報
    The Gap, Inc. - Strategy, SWOT and Corporate Finance Report Summary The Gap, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Iowa Health System:企業の戦略的SWOT分析
    Iowa Health System - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …
  • BankNordik P/F:企業の戦略・SWOT・財務分析
    BankNordik P/F - Strategy, SWOT and Corporate Finance Report Summary BankNordik P/F - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • China Petrochemical Corp:企業のM&A・事業提携・投資動向
    China Petrochemical Corp - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's China Petrochemical Corp Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisiti …
  • Kindred Healthcare Inc (KND):製薬・医療:M&Aディール及び事業提携情報
    Summary Kindred Healthcare Inc (Kindred Healthcare) is a healthcare services provider with focus on post-acute care services. The company through its subsidiaries offers home health, hospice and community care services to patients in homes, nursing centers, and other residential settings. It operate …
  • W&T Offshore Inc Oil & Gas Exploration and Production Operations and Cost Analysis – Q4, 2017
    W&T Offshore Inc Oil & Gas Exploration and Production Operations and Cost Analysis - Q4, 2017 Summary W&T Offshore Inc (W&T Offshore) is an independent oil and natural gas company. It carries out acquisition, exploitation, development and exploration of oil and natural gas assets both onshore and of …
  • EnergySolutions LLC:企業の戦略的SWOT分析
    EnergySolutions LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • Wallenstam AB (WALL B):企業の財務・戦略的SWOT分析
    Summary Wallenstam AB (Wallenstam) is a construction company that offers building and property management solutions. The company's services include commercial and residential properties development, housing programs, property investment and management, urban development, property ownership services, …
  • PT. Asuransi Jiwasraya (Persero):企業の戦略・SWOT・財務分析
    PT. Asuransi Jiwasraya (Persero) - Strategy, SWOT and Corporate Finance Report Summary PT. Asuransi Jiwasraya (Persero) - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Larsen & Toubro Ltd (LT):電力:M&Aディール及び事業提携情報
    Summary Larsen & Toubro Limited (L&T) is an industry conglomerate. It carries out technology, engineering, construction and manufacturing activities. The company offers a broad spectrum of design-to-deliver solutions. Its service portfolio includes basic and detailed engineering, erection and commis …
  • Verrica Pharmaceuticals Inc (VRCA):製薬・医療:M&Aディール及び事業提携情報
    Summary Verrica Pharmaceuticals Inc (Verrica) is a clinical-stage medical dermatology company that discovers, develops and commercializes therapeutics for the treatment of skin diseases. The company’s lead product candidate, VP-102, is in two phase 3 clinical trials for the treatment of molluscum co …
  • Makedonijaturist AD Skopje:企業の戦略・SWOT・財務情報
    Makedonijaturist AD Skopje - Strategy, SWOT and Corporate Finance Report Summary Makedonijaturist AD Skopje - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Entravision Communications Corp (EVC):企業の財務・戦略的SWOT分析
    Entravision Communications Corp (EVC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths an …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆